Abstract:Background: The ability to predict Alzheimers disease (AD) before diagnosis is a topic of intense research. Early diagnosis would aid in improving treatment and intervention options, however, there are no current methods that can accurately predict AD years in advance. This study examines a novel machine learning approach that integrates the combined effects of vascular (white matter hyperintensities, WMHs), and structural brain changes (gray matter, GM) with clinical factors (cognitive status) to predict post-mortem neuropathological outcomes. Methods: Healthy older adults, participants with mild cognitive impairment, and AD from the Alzheimer's Disease Neuroimaging Initiative dataset with both post-mortem neuropathology data and antemortem MRI and clinical data were included. Longitudinal data were analyzed across three intervals before death (post-mortem data): 0-4 years, 4-8 years, and 8-14 years. Additionally, cross-sectional data at the last visit or interval (within four years, 0-4 years) before death were also examined. Machine learning models including gradient boosting, bagging, support vector regression, and linear regression were implemented. These models were applied towards feature selection of the top seven MRI, clinical, and demographic data to identify the best performing set of variables that could predict postmortem neuropathology outcomes (i.e., neurofibrillary tangles, neuritic plaques, diffuse plaques, senile/amyloid plaques, and amyloid angiopathy). Results: A total of 94 participants (55-90 years of age) were included in the study. At last visit, the best-performing model included total and temporal lobe WMHs and achieved r=0.87(RMSE=0.62) during cross-validation for neuritic plaques. For longitudinal assessments across different intervals, the best-performing model included regional GM (i.e., hippocampus, amygdala, caudate) and frontal lobe WMH and achieved r=0.93(RMSE=0.59) during cross-validation for neurofibrillary tangles. For MRI and clinical predictors and clinical-only predictors, t-tests demonstrated significant differences at all intervals before death (t[-13.60-7.90], p-values<0.001). Overall, post-mortem neuropathology outcome were predicted up to 14 years before death with high accuracies (~90%). Conclusions: Prediction accuracy was higher for post-mortem neuropathology outcomes that included MRI (WMHs, GM) and clinical features compared to clinical-only features. These findings highlight that MRI features are critical to successfully predict AD-related pathology years in advance which will improve participant selection for clinical trials, treatments, and intervention options.

Examining stability of machine learning methods for predicting dementia at early phases of the disease

Breaking barriers: a statistical and machine learning-based hybrid system for predicting dementia

Develop a Diagnostic Tool for Dementia Using Machine Learning and Non-Imaging Features

Identifying Alzheimer Disease Dementia Levels Using Machine Learning Methods

Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models

A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction

Prediction of dementia using machine learning model and performance improvement with cuckoo algorithm

A Machine Learning Approach for Predicting Deterioration in Alzheimer's Disease

Performance of Machine Learning Algorithms for Predicting Progression to Dementia in Memory Clinic Patients

A deeply supervised adaptable neural network for diagnosis and classification of Alzheimer's severity using multitask feature extraction

Analysis of Risk Factors in Dementia Through Machine Learning

Exploring the power of MRI and clinical measures in predicting Alzheimers disease neuropathology

Machine learning in neurological disorders: A multivariate LSTM and AdaBoost approach to Alzheimer's disease time series analysis

Performances of Machine Learning Models for Diagnosis of Alzheimer’s Disease

Patterns of structure-function association in normal aging and in Alzheimer's disease: Screening for mild cognitive impairment and dementia with ML regression and classification models

Multimodal Data Integration for Early Alzheimer’s Detection Using Random Forest and Support Vector Machines

Improving Alzheimer's Disease Prediction with Different Machine Learning Approaches and Feature Selection Techniques

An explainable machine learning approach for Alzheimer's disease classification

Predicting the Progression of Mild Cognitive Impairment Using Machine Learning: A Systematic, Quantitative and Critical Review

Application of machine learning in dementia diagnosis: A systematic literature review

Machine and deep learning algorithms for classifying different types of dementia: A literature review